Advisory committee

/

Prof Mark Hatherill (Chair)

Director, South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town

Dr Carol Holm-Hansen

Senior scientist, Norwegian Institute of Public Health Oslo, Norway

Prof Willem Hanekom

Director of the Africa Health Research Institute (AHRI) in KwaZulu-Natal, South Africa.

Dr Gerd Zettlmeissl

Former CEO Valneva SE (formerly Intercell AG) Vienna, Austria

Ingrid Murillo Jelsbak

Clinical Research Director at Biofabri, Porriño, Spain

Frank Cobelens MD MSc PhD

Professor of Global Health at the Amsterdam University Medical Centers, loc. AMC, UvA, & Amsterdam Inst. for Global health & Devel. (AIGHD)

Morten Ruhwald
MD PhD

Head of TB program, Foundation of Innovative New Diagnostics (FIND).

Dr Eugene Sun

Senior Vice President, Research and Development for the TB Alliance

Dr Thomas Nyirenda MD MPH

Strategic Partnerships and Capacity Development Manager of EDCTP

Ann M. Ginsberg
MD PhD

Deputy Director, TB Vaccines, the Bill & Melinda Gates Foundation

Mercè Amat

R&D manager Archivel Farma

Dr Gerald Voss

Scientific Director

Advisory committee